BioLife Solutions (BLFS) Competitors $21.09 +0.36 (+1.74%) Closing price 04:00 PM EasternExtended Trading$21.09 0.00 (0.00%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLFS vs. INSP, NVST, PRCT, WRBY, LIVN, EYE, LMAT, CNMD, LQDA, and ENOVShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), LeMaitre Vascular (LMAT), CONMED (CNMD), Liquidia Technologies (LQDA), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. Its Competitors Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision LeMaitre Vascular CONMED Liquidia Technologies Enovis BioLife Solutions (NASDAQ:BLFS) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk. Do analysts prefer BLFS or INSP? BioLife Solutions presently has a consensus price target of $31.00, indicating a potential upside of 46.99%. Inspire Medical Systems has a consensus price target of $173.31, indicating a potential upside of 120.68%. Given Inspire Medical Systems' higher possible upside, analysts plainly believe Inspire Medical Systems is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54 Is BLFS or INSP more profitable? Inspire Medical Systems has a net margin of 6.17% compared to BioLife Solutions' net margin of -11.81%. Inspire Medical Systems' return on equity of 10.39% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-11.81% -0.66% -0.58% Inspire Medical Systems 6.17%10.39%9.00% Which has more volatility & risk, BLFS or INSP? BioLife Solutions has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Does the media refer more to BLFS or INSP? In the previous week, Inspire Medical Systems had 46 more articles in the media than BioLife Solutions. MarketBeat recorded 50 mentions for Inspire Medical Systems and 4 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 1.38 beat Inspire Medical Systems' score of 0.43 indicating that BioLife Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 18 Very Positive mention(s) 6 Positive mention(s) 11 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in BLFS or INSP? 93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 2.3% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, BLFS or INSP? Inspire Medical Systems has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M12.26-$20.18M-$0.29-72.72Inspire Medical Systems$802.80M2.88$53.51M$2.1736.19 SummaryInspire Medical Systems beats BioLife Solutions on 11 of the 15 factors compared between the two stocks. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.01B$10.35B$5.50B$9.55BDividend YieldN/A2.00%4.71%4.14%P/E Ratio-72.7219.3728.7823.91Price / Sales12.2626.30438.5395.15Price / Cash170.5122.1035.6858.35Price / Book2.803.558.225.62Net Income-$20.18M$211.77M$3.25B$265.35M7 Day Performance-3.35%-0.23%-0.73%-0.89%1 Month Performance-9.33%3.19%5.52%4.98%1 Year Performance-7.82%-10.82%28.79%23.50% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions2.9318 of 5 stars$21.09+1.7%$31.00+47.0%-6.2%$1.01B$82.25M-72.72440Upcoming EarningsINSPInspire Medical Systems4.6412 of 5 stars$130.79+3.7%$208.55+59.5%-40.8%$3.72B$802.80M60.271,246Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeNVSTEnvista3.4994 of 5 stars$20.48-1.7%$20.92+2.2%+27.2%$3.46B$2.51B63.9912,300Trending NewsEarnings ReportAnalyst RevisionPRCTPROCEPT BioRobotics2.7843 of 5 stars$49.60-0.7%$84.13+69.6%-14.5%$2.76B$249.12M-29.18430News CoveragePositive NewsEarnings ReportWRBYWarby Parker2.0515 of 5 stars$24.47+3.7%$23.13-5.5%+62.3%$2.47B$771.32M-203.883,780Upcoming EarningsAnalyst ForecastAnalyst RevisionLIVNLivaNova3.1988 of 5 stars$42.76+4.0%$59.29+38.6%-5.8%$2.24B$1.25B-10.452,900News CoveragePositive NewsEYENational Vision3.0549 of 5 stars$25.07+3.6%$24.18-3.5%+82.3%$1.91B$1.82B-75.9713,411News CoveragePositive NewsEarnings ReportLMATLeMaitre Vascular2.3669 of 5 stars$84.36+4.1%$97.83+16.0%+6.4%$1.83B$219.86M42.61490Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastGap UpCNMDCONMED4.4171 of 5 stars$53.46+2.2%$59.80+11.9%-18.7%$1.62B$1.31B15.153,900Earnings ReportLQDALiquidia Technologies3.4174 of 5 stars$19.48+10.2%$26.89+38.0%+82.3%$1.51B$14M-12.3350Upcoming EarningsENOVEnovis2.9193 of 5 stars$26.61+3.4%$55.60+109.0%-36.7%$1.47B$2.11B-1.917,367Upcoming Earnings Related Companies and Tools Related Companies Inspire Medical Systems Competitors Envista Competitors PROCEPT BioRobotics Competitors Warby Parker Competitors LivaNova Competitors National Vision Competitors LeMaitre Vascular Competitors CONMED Competitors Liquidia Technologies Competitors Enovis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLFS) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredDebt Crisis Warning: How to Protect Your Wealth Before August 31stOn August 31st, the U.S. runs out of “extraordinary measures” to avoid default—and Washington insiders are alr...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLFS Stock Alerts